Human Rights and the Regulation of Transnational Clinical Trials

Roland Pierik

Political Studies, 2015, vol. 63, issue 4, 870-886

Abstract: type="main">

One of the more worrying trends in globalization today is the growing practice of Western companies relocating clinical trials to impoverished countries. This article begins by providing a comprehensive description of the practice and its current regulatory oversight. It is argued that this regulatory scheme is insufficient for protecting the interests of test subjects in such relocated trials. The article then suggests an alternative scheme, embedded in the general framework of human rights protections, and develops the contours of such a human-rights-based regulatory scheme. It concludes by arguing why this alternative regulatory framework does a better job of protecting the interests of test subjects than those regulatory schemes currently available: the Declaration of Helsinki and the statement of Good Clinical Practice.

Date: 2015
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1111/1467-9248.12134 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bla:polstu:v:63:y:2015:i:4:p:870-886

Ordering information: This journal article can be ordered from
http://www.blackwell ... bs.asp?ref=0032-3217

Access Statistics for this article

Political Studies is currently edited by Matthew Festenstein and Martin Smith

More articles in Political Studies from Political Studies Association
Bibliographic data for series maintained by Wiley Content Delivery ().